| Dr Erika Barlow Brandenstein, MD | |
|
1050 Reid Pkwy, Suite 220, Richmond, IN 47374-1160 | |
| (765) 962-9541 | |
| (765) 966-5952 |
| Full Name | Dr Erika Barlow Brandenstein |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 1050 Reid Pkwy, Richmond, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558565614 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 01069984A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reid Hospital & Health Care Services | Richmond, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reid Physician Associates, Inc. | 6406910769 | 338 |
| Reid Physician Associates, Inc. | 6406910769 | 338 |
News Archive
The lifetime risk of getting breast cancer has risen from one woman in nine to one in eight - according to Cancer Research UK.
With antibiotic resistant infections on the rise and a scarce pipeline of novel drugs to combat them, researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center are pursuing entirely new approaches to meet the challenge of drug-resistant infections by taming microbes rather than killing them.
More than two thousand physicians, some of the top obstetric/gynecologists in the world who specialize in maternal-fetal medicine, especially high risk pregnancies, gathered today for their annual meeting in San Francisco to begin four days of intensive research presentations. Presentations each year at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, represent major findings in reducing high-risk pregnancies and complications.
Liver transplant patients with hepatitis C virus (HCV) achieved significantly better long-term viral response when taking the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination therapy. Cyclosporine also showed efficacy against Hepatitis C virus in vitro.
LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools, developed by Dr. Manuel S. Rodriguez of the proteomics unit of the CICbioGUNE in Spain, will be launched in October 2009.
› Verified 9 days ago
| Entity Name | Reid Physician Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265689111 PECOS PAC ID: 6406910769 Enrollment ID: O20090130000573 |
News Archive
The lifetime risk of getting breast cancer has risen from one woman in nine to one in eight - according to Cancer Research UK.
With antibiotic resistant infections on the rise and a scarce pipeline of novel drugs to combat them, researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center are pursuing entirely new approaches to meet the challenge of drug-resistant infections by taming microbes rather than killing them.
More than two thousand physicians, some of the top obstetric/gynecologists in the world who specialize in maternal-fetal medicine, especially high risk pregnancies, gathered today for their annual meeting in San Francisco to begin four days of intensive research presentations. Presentations each year at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, represent major findings in reducing high-risk pregnancies and complications.
Liver transplant patients with hepatitis C virus (HCV) achieved significantly better long-term viral response when taking the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination therapy. Cyclosporine also showed efficacy against Hepatitis C virus in vitro.
LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools, developed by Dr. Manuel S. Rodriguez of the proteomics unit of the CICbioGUNE in Spain, will be launched in October 2009.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erika Barlow Brandenstein, MD 1100 Reid Pkwy, Medical Staff Services, Richmond, IN 47374-1157 Ph: (765) 962-9541 | Dr Erika Barlow Brandenstein, MD 1050 Reid Pkwy, Suite 220, Richmond, IN 47374-1160 Ph: (765) 962-9541 |
News Archive
The lifetime risk of getting breast cancer has risen from one woman in nine to one in eight - according to Cancer Research UK.
With antibiotic resistant infections on the rise and a scarce pipeline of novel drugs to combat them, researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center are pursuing entirely new approaches to meet the challenge of drug-resistant infections by taming microbes rather than killing them.
More than two thousand physicians, some of the top obstetric/gynecologists in the world who specialize in maternal-fetal medicine, especially high risk pregnancies, gathered today for their annual meeting in San Francisco to begin four days of intensive research presentations. Presentations each year at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, represent major findings in reducing high-risk pregnancies and complications.
Liver transplant patients with hepatitis C virus (HCV) achieved significantly better long-term viral response when taking the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination therapy. Cyclosporine also showed efficacy against Hepatitis C virus in vitro.
LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools, developed by Dr. Manuel S. Rodriguez of the proteomics unit of the CICbioGUNE in Spain, will be launched in October 2009.
› Verified 9 days ago
Dr. Marvin Scott Haswell, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1050 Reid Parkway, Suite 220, Richmond, IN 47374 Phone: 765-962-9541 Fax: 765-966-5952 | |
Thomas A Duncan, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1050 Reid Pkwy Ste 220, Richmond, IN 47374 Phone: 765-962-9541 Fax: 765-966-5952 | |
Dr. Richard N Woodruff, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1050 Reid Parkway, Suite 220, Richmond, IN 47374 Phone: 765-962-9541 Fax: 765-966-5952 | |
Dr. Sara I. Diaz Valentin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1050 Reid Pkwy Ste 325, Urological Care, Richmond, IN 47374 Phone: 765-962-8551 Fax: 765-962-2591 | |
Dr. Martha E Fagan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1050 Reid Parkway, Suite 220, Richmond, IN 47374 Phone: 765-962-9541 Fax: 765-966-5952 | |
Dr. Joseph B Clemente, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1050 Reid Parkway, Suite 220, Richmond, IN 47374 Phone: 765-962-9541 Fax: 765-966-5952 |